Ultraviolet light modulation of autoantigens, epidermal cytokines and adhesion molecules as contributing factors of the pathogenesis of cutaneous LE

Lupus

Volumn 6, Issue 2, 1997, Pages 181-192

  Bennion, S D ^a   Norris, D A ^b  

^a FITZSIMONS ARMY MEDICAL CENTER   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Adhesion molecules; Apoptosis; Autoantigens; Cytokines; Lupus erythematosus; Ultraviolet light

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; CELL ADHESION MOLECULE; CYTOKINE;

ARTICLE; EPIDERMIS; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; INFLAMMATION; PRIORITY JOURNAL; SKIN LUPUS ERYTHEMATOSUS; ULTRAVIOLET RADIATION;

EID: 0031040589     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/096120339700600214     Document Type: Article

References (116)

1. Feint H. Light as an exciting agent in lupus erythematosus and other dermatoses. J Med Soc NJ 1996; 24: 226-228
2. Naer R. Jamer LC. Photobiology of lupus erythematosus. Arch Dermatol 1965; 92: 124-128.
3. Epstein JH, Tuffanelli D, Dubois EL. Light sensitivity and lupus erythematosus. Arch Dermatol 1965; 91: 483-485.
4. Everett MA, Olson RL. Response of cutaneous lupus erythematosus to ultraviolet light. J Invest Dermatol 1965; 44: 133-139.
5. Fronek Z et al. Major histocompatibility complex genes and susceptibility to systemic lupus erythematosus. Arthritis Rheum 1990; 33: 1542-1553.
6. Wysenbeek AJ, Block DA, Fries JF. Prevalence and expression of photosensitivity in systemic lupus erythematosus. Ann Rheum Dis 1989; 48: 461-463.
7. Tan EM et al. Criteria for the classification of systemic lupus erythematosus Arth Rheum 1984; 27: 530-538.
8. Lehmann P et al. Experimental reproduction of skin lesions in lupus erythematosus by UVA and UVB radiation. J Am acad Dermatol 1990; 22: 181-187.
9. Luger TA, Schwarz T. Evidence for an epidermal cytokine network. J Invest Dermatol 1990; 95: 100S-104S.
10. Schroder JM. Cytokine networks in the skin, [review]. J Invest Dermatol 1995; 105: 20S-24S.
11. Anderson, RR, Parrish JA. The optics of human skin. J Invest Dermatol 1981; 77: 13-19.
12. Cripps DJ, Rankin J. Action spectra of lupus erythematosus and experimental immunofluorescence. Arch Dermatol 1973, 107: 563-567.
13. Freeman RG, Knox JM. Cutaneous lesions of lupus erythematosus induced by monochromatic light. Arch Dermatol 1969; 100: 677-682.
14. Kochevar I. Action spectrum and mechanism of UV-radiation-induced injury in lupus erythematosus. J Invest Dermatol 1985; 85: 140S-143S.
15. Hozle E. Photodermatoses-diagnostic procedures and their interpretation. Photodermatol 1987; 4: 109-114.
16. Kind P, Lehmann P, Plewig G. Phototesting in lupus erythematosus. J Invest Dermatol 1993; 100: 53S-57S.
17. Mond CB, Peterson MG, Rothfield NF. Correlation of anti-Ro antibody with photosensitivity rash in systemic lupus erythematosus patients. Arthritis Rheum 1989; 32: 202-204.
18. Black AK, Fincham N, Greaves MW, Hensby CN. Time course changes in levels of arachidonic acid and prostaglandins D2, E2, F2 alpha in human skin following ultraviolet B irradiation. Br J Clin Pharmacol 1980; 10: 453-457.
19. Greaves MW, Sondergaard J. Pharmacologic agents released in ultraviolet inflammation studied by continuous skin perfusion. J Invest Dermatol 1970; 54: 365-367.
20. Hensby CN et al. Time-course of arachidonic acid, prostaglandins E2 and F2 alpha production in human abdominal skin, following irradiation with ultraviolet wavelengths (290-320 nm). Adv Prostaglandin Thromboxane Res 1980; 7: 857-860.
21. Bennion S et al. The effect of UVB on 6-Keto-PGF1a production by cultured human endothelial cells. J Invest Dermatol 1984; 82: 428a.
22. Hawk JL et al. Increased concentrations of arachidonic acid, prostaglandins E2, D2, and 6-oxo-F1 alpha, and histamine in human skin following UVA irradiation. J Invest Dermatol 1983; 80: 496-499.
23. Kupper TS et al. Interleukin 1 gene expression in cultured human keratinocytes is augmented by ultraviolet irradiation. J Clin Invest 1987; 80: 430-436.
24. Granstein RD, Sander DN. Whole-body exposure to ultraviolet radiation results in increased serum interleukin-1 activity in humans. Lymphokine Res 1987; 6: 187-193.
25. Mizutani H, Black R, Kupper TS. Human keratinocytes produce but do not process pro-interleukin-1 (IL-1) beta. Different strategies of IL-1 production and processing in monocytes and keratinocytes. J Clin Invest 1991; 87: 1066-1071.
26. Bigler CF, Norris DA, Weston WL, Arend WP. Interleukin-1 receptor antagonist production by human keratinocytes. J Invest Dermatol 1992; 98: 38-44.
27. Kupper TS, Groves RW. The interleukin-1 axis and cutaneous inflammation. [review]. J Invest Dermatol 1995; 105: 62S-66S.
28. Kock A et al. Human keratinocytes are a source for tumor necrosis factor alpha: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. J Exp Med 1990; 172: 1609-1614.
29. Middleton MH, Norris DA. Cytokin-induced icam-1 expression in human keratinocytes is highly variable in keratinocyte strains from different donors. J Invest Dermatol 1995; 104: 489-496.
30. Kurimoto I, Streilein JW. cis-urocanic acid suppression of contact hypersensitivity induction is mediated via tumor necrosis factor-alpha. J Immunol 1992; 148: 3072-3078.
31. Vinek V. Sunlight induced progression of aids. [review]. Med Hypotheses 1995; 44: 119-123.
32. Walsh LJ. Ultraviolet b irradiation of skin induces mast cell degranulation and release of tumour necrosis factor-alpha. Immunol Cell Biol 1995; 73: 226-233.
33. Amse; K et al. Cytokine m odulation of keratinocyte cytokines. J Invest Dermatol 1990; 94: 101S-107S.
34. Kupper TS. Mechanisms of cutaneous inflammation. Arch Dermatol 1989; 125: 1406-1412.
35. Chouaib S, Branellec D, Buurman WA. More insights into the complex physiology of TNF. Immunol Today 1991; 12: 141-142.
36. Jacob CO. Studies on the role of tumor necrosis factor in murine and human autoimmunity. J Autoimmun 1992; 5: 133-143.
37. Kirnbauer R et al. IFN-beta 2, B cell differentiation factor 2, or hybridoma growth factor (IL-6) is expressed and released by hjuman epidermal cells and epidermoid carcinoma cell lines. J Immunol 1989; 142: 1922-1928.
38. Urbanski A et al. Ultraviolet light induces increased circulating interleukin-6 in humans. J Invest Dermatol 1990; 94: 808-811.
39. Turksen K et al. Interleukin 6: insights to its function in skin by overexpression in transgenic mice. Proc Natl Acad Sci (USA) 1992; 89: 5068-5072.
40. Aberer W et al. Ultraviolet light depletes surface markers of Langerhans cells. J Invest Dermatol 1981; 76: 202-210.
41. Yoshikawa T, Kurimoto I, Streilein JW. Tumour necrosis factor-alpha mediates ultraviolet light B-enhanced expression of contact hypersensitivity. Immunol 1992; 76: 264-271.
42. Beissert S, Ullrich SE, Hosoi J, Granstein RD. Supernants from uvb radiation-exposed keratinocytes inhibit langerhans cell presentation of tumor-associated antigens via il-10 content. J Leuk Biol 1995; 58: 234-240.
43. Ullrich SE. Mechanism involved in the systemic suppression of antigen-presenting cell function by uv irradiation. Keratinocyte-derived IL-10 modulates antigen-presenting cell function of splenic adherent cells. J Immunol 1994; 152: 3410-3416.
44. Krutmann K. Grewe Involvement of cytokines, dna damage, and reactive oxygen intermediates in ultraviolet radiation-induced modulation of intercellular adhesion molecule-1 expression/ [review]. J Invest Dermatol 1995; 105: 67S-70S.
45. Grewe K, Gyufko K, Krutmann J. Interleukin-10 production by cultured human keratinocytes: regulation by ultraviolet b and ultraviolet al radiation. J Invest Dermatol 1995; 104: 3-6.
46. el-Ghorr AA, Norval M. A monoclonal antibody to cis-urocanic acid prevents the ultraviolet-induced changes in langerhans cells and delayed hypersensitivity responses in mice, although not preventing dendritic cell accumulation in lymph nodes draining the site of irradiation and contact hypersensitivity responses. J Invest Dermatol 1995; 105: 264-268.
47. Muller G et al. IL-12 as mediator and adjuvant for the induction of contact sensitivity in vivo. J Immunol 1995; 155: 4661-4668.
48. Davis TL, Lyde CB, Davis BM, Sontheimer RD. Perturbation of experimental ultraviolet light-induced erythema by passive transfer of serum from subacute cutaneous lupus erythematosus patients. J Invest Dermatol 1989; 92: 573-577.
49. Norris DA. Cytokine modulation of adhesion molecules in the regulation of immunologic cytotoxicity of epidermal targets. J Invest Dermatol 1990; 95: 111S-120S.
50. Norris DA. Immune Mechanisms in Cutaneous Disease. Marcel Dekker, Inc; New York, NY, 1989 pp 123-166.
51. Dustin ML, Singer KH, Tuck DT, Springer TA. Adhesion of T lymphoblasts to epidermal keratinocytes is regulated by interferon-gamma and is mediated by intercellular adhesion molecule-1 (ICAM-1). J Exp Med 1988; 167: 1323-1340.
52. Makgoba MW et al. Functional evidence that intercellular adhesion molecule 1 (ICAM-1) is a ligand for LFA-1 dependent adhesion in T cell-mediated cytotoxicity. Eur J Immunol 1988; 18: 637-640.
53. Makgoba MW et al. ICAM-1 a ligand for LFA-1 dependent adhesion by B, T and myeloid cells. Nature 1988; 331: 86-91.
54. Dustin ML et al. A natural adherence molecule (ICAM-1): Induction by IL-1 and interferon gamma, tissue distribution, and function. J Immunol 1986; 137: 245-254.
55. Kashihara Sawami M, Norris DA. The state of differentiation of cultured human keratinocytes determines the level of intercellular adhesion molecule-1 (ICAM-1) expression induced by gamma interferon. J Invest Dermatol 1992; 98: 741-747.
56. Norris DA et al. Ultraviolet radiation can either suppress or induce expression of intercellular adhesion molecule 1 (ICAM-1) on the surface of cultured human keratinocytes. J Invest Dermatol 1990; 95: 132-138.
57. Bennion SD et al. In three types of interface dermatitis, different patterns of expression of intercellular adhesion molecule-1 (icam-1) indicate different triggers of disease. J Invest Dermatol 1995; 105: 71S-79S.
58. Barker JNWN et al. Marked synergism between tumor necrosis factor alpha and interferon-gamma in regulation of keratinocyte-derived chemotactic factors and adhesion molecules. J Clin Invest 1990; 95: 605-608.
59. Stephansson E, Ros AM. Expression of intercellular adhesion molecule-l (icam-1) and okm5 in uva- and uvb-induced lesions in patients with lupus erythematosus and polymorphous light eruption. Arch Dermatol Res 1993; 285: 328-333.
60. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994; 76: 301-314.
61. Simon SI et al. L-selectin (cd621) cross-linking signals neutrophil adhesive functions via the MAC-1 (CD11b/CD18) beta 2-integrin. J Immunol 1995; 155: 1502-1514.
62. Huang AJ et al. Endothelial cell cytosolic free calcium regulates neutrophil migration across monolayers of endothelial cells. J Cell Biol 1993; 120: 1371-1380.
63. Beynon HL et al. Combinations of low concentrations of cytokines and acute agonists synergize in increasing the permeability of endothelial monolayers. Clin Exp Immunol 1993; 91: 314-319.
64. Cornelius LA et al. Selective upregulation of intercellular adhesion molecule (ICAM-1) by ultraviolet b in human dermal microvascular endothelial cells. J Invest Dermatol 1994; 103: 23-28.
65. Norris P et al. The expression of endothelial leukocyte adhesion molecule-1 (ELAM-1), intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) in experimental cutaneous inflammation: a comparison of ultraviolet B erythema and delayed hypersensitivity. J Invest Dermatol 1991; 96: 763-770.
66. Sauder DN, Wong D, Laskin C. Epidermal cytokines in murine lupus. J Invest Dermatol 1993; 100: 42S-46S.
67. Velthuis PJ, vanWeelden H, vanWichen D, BaartdelaFaille H. Immunohistopathology of light-induced skin lesions in lupus erythematosus. Acta Derm Venereol (Stockholm) 1990; 70: 93-98.
68. Sontheimer RD, Bergstresser PR. Epidermal Langerhans cell involvement in cutaneous lupus erythematosus. J Invest Dermatol 1982; 79: 237-243.
69. Volc Platzer et al. Accumulation of gamma delta T cells in chronic cutaneous lupus erythematosus. J Invest Dermatol 1993; 100: 84S-91S.
70. Kaufmann SHE. Heat shock proteins and the immune response. Immunol Today 1990; 11: 129-136.
71. Norton PM, Isenberg DA, Latchman DS. Elevated levels of the 90 kd heat shock protein in a proportion of SLE patients with active disease. J Autoimmun 1989; 2: 187-195.
72. Norris DA. Pathomechanisms of photosensitivie lupus erythematosus. J Invest Dermatol 1993; 100: 58S-68S.
73. Sontheimer et al. Serologic and HLA associations in subacute cutaneous lupus erythematosus: a clinical subset of lupus erythematosus. Ann Int Med 1982; 97: 664-671.
74. Weston WL, Harmon C, Peebles C. A serologic marker for neonatal lupus. Brit J Dermatol 1982; 107: 377-382.
75. Sontheimer RD. Questions pertaining to the true frequencies with which anti-Ro/SS-A autoantibody and the HLA-DR3 phenotype occur in subacute cutaneous lupus erythematosus patients. J Am Acad Dermatol 1987; 16: 130-134.
76. Lee LA, David KM. Cutaneous lupus erythematosus. Curr Probl Dermatol 1989; 1: 161-210.
77. Buyon JP et al. Acquired congenital heart block. Pattern of maternal antibody response to biochemically defined antigens of the SSA/Ro-SSB/La system in neonatal lupus. J Clin Invest 1989; 84: 627-634.
78. McCauliffe DP, Sontheimer RD. Molecular characterization of the Ro/SS-A autoantigens. J Invest Dermatol 1993; 100: 73S-79S.
79. Lee LA et al. Autoantibody Markers of Cutaneous Lupus Erythematosus. J Invest Dermatol 1993; 100: 573.
80. Provost TT, Herrera-Esparaza R, Diaz LA. Nucleoprotein autoantibodies in lupus erythematosus. J Invest Dermatol 1985; 85: 133S-139S.
81. David Bajar KM et al. Clinical, histologic, and immunofluorescent distinctions between subacute cutaneous lupus erythematosus and discoid lupus erythematosus. J Invest Dermatol 1992; 99: 251-257.
82. Fabre VC et al. Twenty percent of biopsy specimens from sun-exposed skin of normal young adults demonstrate positive immunofluorescence [see comments]. Arch Dermatol 1991; 127: 1006-1011.
83. Leibold AM, Bennion S, David-Bajar K, Schleve MJ. Occurrence of positive immunofluorescence in the dermo-epidermal junction of sun-exposed skin of normal adults J Cutan Pathol 1994; 21: 200-206.
84. Jablonska S, Blaszezyk M. Sclerodermalike diseases/ [review]. Clin Dermatol 1994; 12: 437-448.
85. Ansel JC et al. Effects of UV radiation on autoimmune strains of mice: increased mortality and accelerated autoimmunity in BXSB male mice. J Invest Dermatol 1985; 85: 181-186.
86. Natali PG, Tan EM. Experimental skin lesions in mice resembling systemic lupus erythematosus. Arthritis Rheum 1973; 16: 579-589.
87. LeFeber WP et al. Ultraviolet light induces binding of antibodies to selected nuclear antigens on cultured human keratinocytes. J Clin Invest 1984; 74: 1545-1551.
88. Furukawa et al. Binding of antibodies to the extractable nuclear antigens SS- A/RO and SS-B/La is induced on the surface of human keratinocytes by ultraviolet light (UVL): implications for the photogenesis of photosensitive cutaneous lupus. 1990; 94: 77-85.
89. Jones SK. The effects of hormonal and other stimuli on cell-surface Ro/SSA antigen expression by human keratinocytes in vitro: their possible role in the induction of cutaneous lupus lesions. Br J Dermatol 1992; 126: 554-560.
90. Jones SK. Ultraviolet radiation (UVR) induces cell-surface Ro/SSA antigen expression by human keratinocytes in vitro: a possible mechanism for the UVR induction of cutaneous lupus lesions. Br J Dermatol 1992; 126: 546-553.
91. Casciola-Rosen LA, Anhalt G, Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes [see comments]. J Exp Med 1994; 179: 1317-1330.
92. Tan EM. Autoimmunity and apoptosis [comment]. J Exp Med 1994; 179: 1083-1086.
93. Golan TD, Elkon KB, Gharavi AE, Krueger JG. Enhanced membrane binding of autoantibodies to cultured keratinocytes of systemic lupus erythemtosus patients after ultraviolets/ultraviolet A radiation. J Clin Invest 1992; 90: 1067-1076.
94. Furukawa F et al. Estradiol enhances binding to cultured human keratinocytes of antibodies specific for SS-A/RO and SS/B/La. Another possible mechanism for estradiol influence of lupus erythematosus. J Immunol 1988; 141: 1480-1488.
95. Lee LA et al. Pattern of cutaneous immunoglobulin G deposition in subacute cutaneous lupus erythematosus is reproduced by infusing purified anti-Ro (SSA) autoantibodies into human skin-grafted mice. J Clin Invest 1989; 83: 1556-1562.
96. Nieboer C, Tak Diamand Z, VanLeeuwen Wallau HE. Dust-like particles: a specific direct immunofluorescence pattern in sub-acute cutaneous lupus erythematosus. Br J Dermatol 1988; 118: 725-729.
97. Golan TD, Gharavi AE, Elkon KB. Penetration of autoantibodies into living epithelial cells. J Invest Dermatol 1993; 100: 316-322.
98. Norris DA et al. The role of RNP, Sm, and SS-A/Ro-specific antisera from patients with lupus erythematosus in inducing antibody-dependent cellular cytotoxicity (ADCC) of targets coated with nonhistone nuclear antigens. Clin Immunol Immunopathol 1984; 31: 311-320.
99. Bennion SD et al. IgG subclasses in the serum and skin in subacute cutaneous lupus erythematosus and neonatal lupus erythematosus. J Invest Dermatol 1990; 95: 643-646.
100. Norris DA et al. Systematic comparison of antibody-mediated mechanisms of keratinocyte lysis MIT ε. J Immunol 1985; 135: 1073-1079.
101. Furukawa F, Kanauchi H, Imamura S. Susceptibility to uvb light in cultured keratinocytes of cutaneous lupus erythematosus. Dermatology 1994; 189 (Suppl. 1): 18-23.
102. Norris DA, Lee LA. Antibody-dependent cellular cytotoxicity and skin disease. J Invest Dermatol 1985; 85: 165S-175S.
103. Bangert JL, Freeman RG, Sontheimer RD, Gilliam JN. Subacute cutaneous lupus erythematosus and discoid lupus erythematosus. Comparative histopathologic findings. Arch Dermatol 1984; 120: 332-337.
104. Cohen JJ. Apoptosis. Immunol Today 1993; 14: 126-130.
105. Fadok VA et al. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 1992; 148: 2207-2216.
106. Norris DA. Editorial: Differential control of cell death in the skin. Arch Dermatol 1995; 131: 945-548.
107. Wright SC et al Apoptosis and DNA fragmentation precede TNF-induced cytolysis in U937 cells. J Cell Biochem 1992; 48: 344-355.
108. Lowin B, Beermann F, Schmidt A, Tschopp J. A null mutation in the perform gene impairs cytolytic t lymphocyte- and natural killer cell-mediated cytotoxicity. Proc Natl Acad Sci (USA) 1994; 91: 11571-11575.
109. Lowin B, Hahne M, Mattmann C, Tschopp J. Cytolytic t-cell cytotoxicity is mediated through perforin and fas lytic pathways. Nature 1994; 370: 650-652.
110. Irmler M et al. Granzyme a is an interleukin 1 beta-converting enzyme. J Exp Med 1995; 181: 1917-1922.
111. Stalder T, Hahn S, Erb P. Fas antigen is the major target molecule for CD4+ T cell-mediated cytotoxicity. J Immunol 1994; 152: 1127-1133.
112. Suda T, Takahashi T, Golstein P, Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993; 75: 1169-1178.
113. Budtz PE, Spies I. Epidermal tissue homeostasis: apoptosis and cell emigration as mechanisms of controlled cell deletion in the epidermis of the toad, Bufo bufo. Cell Tissue Res 1989; 256: 475-486.
114. Weedon D, Strutton G. Apoptosis as the mechanism of the involution of hair follicles in catagen transformation. Acta Derm Venereol (Stockholm) 1981; 61: 335-3399.
115. McCall CA, Cohen JJ. Progrmamed cell death in terminally differentiating keratinocytes: role of endogenous endonuclease. J Invest Dermatol 1991; 97: 111-114.
116. Weedon D. Apoptosis in lichen planus. Clin Exp Dermatol 1980; 5: 425-430.